^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    naratuximab emtansine (DEBIO 1562)

    i
    Other names: DEBIO 1562, K7153A-SMCC-DM1, K7153A, IMGN-529, IMGN529
    Associations
    News
    Trials
    Company:
    AbbVie, Debiopharm
    Drug class:
    Microtubule inhibitor, CD37-targeted antibody-drug conjugate
    Related drugs:
    Associations
    News
    Trials